Malaria vaccine being developed by GSK is only partially effective against the disease. Scientists suggest that the results of the clinical trials are disappointing, but the study is not a complete waste.
Malaria vaccine being developed by GSK is only partially effective against the disease. Scientists suggest that the results of the clinical trials are disappointing, but the study is not a complete waste.
Share this Article
Recommended